PROK
Price
$1.72
Change
+$0.01 (+0.58%)
Updated
Oct 2 closing price
Capitalization
336.37M
45 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$4.12
Change
+$0.05 (+1.23%)
Updated
Oct 2 closing price
Capitalization
2B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PROK vs RXRX

PROK vs RXRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PROK vs. RXRX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROK is a StrongBuy and RXRX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
PROKRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 22 days ago
86%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (PROK: $1.71 vs. RXRX: $4.07)
Brand notoriety: PROK and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PROK: 104% vs. RXRX: 99%
Market capitalization -- PROK: $336.37M vs. RXRX: $2B
PROK [@Biotechnology] is valued at $336.37M. RXRX’s [@Biotechnology] market capitalization is $2B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROK’s FA Score shows that 0 FA rating(s) are green while RXRX’s FA Score has 1 green FA rating(s).

  • PROK’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROK’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • PROK’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PROK is a better buy in the short-term than RXRX.

Price Growth

PROK (@Biotechnology) experienced а +1.79% price change this week, while RXRX (@Biotechnology) price change was +4.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

PROK is expected to report earnings on Nov 16, 2026.

RXRX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PROK
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USDX25.630.01
+0.04%
SGI Enhanced Core ETF (USDX)
SUSC21.92-0.02
-0.11%
iShares ESG Aware USD Corporate Bond ETF (SUSC)
TTXD11.82-0.02
-0.19%
Direxion Daily Technology Top 5 Bear 2X ETF (TTXD)
BCLO49.79-0.22
-0.45%
iShares BBB-B CLO Active ETF (BCLO)
LUNL3.22-0.08
-2.42%
Defiance Daily Target 2X Long LUNR ETF

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+3.01%
RXRX - PROK
55%
Loosely correlated
-1.45%
NKTX - PROK
48%
Loosely correlated
-2.29%
SANA - PROK
47%
Loosely correlated
-0.86%
EDIT - PROK
45%
Loosely correlated
-1.95%
IMTX - PROK
44%
Loosely correlated
-3.87%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with PRME. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-1.45%
PRME - RXRX
65%
Loosely correlated
-2.13%
CRSP - RXRX
64%
Loosely correlated
+0.22%
ABSI - RXRX
61%
Loosely correlated
-0.19%
BEAM - RXRX
59%
Loosely correlated
-0.25%
ABCL - RXRX
59%
Loosely correlated
-4.66%
More